{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:43:06Z","timestamp":1794537786880,"version":"4.9.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41582-025-01081-y","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T02:11:20Z","timestamp":1743819080000},"page":"283-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Multiple sclerosis: an immune attack on astrocyte-mediated ion and water homeostasis"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8912-0954","authenticated-orcid":false,"given":"Marjo S.","family":"van der Knaap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-7599","authenticated-orcid":false,"given":"Rogier","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","volume":"145","author":"R Hoftberger","year":"2017","unstructured":"Hoftberger, R. & Lassmann, H. Inflammatory demyelinating diseases of the central nervous system. Handb. Clin. Neurol. 145, 263\u2013283 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"1081_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1212\/WNL.0b013e318249f6f0","volume":"78","author":"G Disanto","year":"2012","unstructured":"Disanto, G., Morahan, J. M., Barnett, M. H., Giovannoni, G. & Ramagopalan, S. V. The evidence for a role of B cells in multiple sclerosis. Neurology 78, 823\u2013832 (2012).","journal-title":"Neurology"},{"key":"1081_CR3","unstructured":"Love, S., Perry, A., Ironside, J. & Budka, H. Greenfield\u2019s Neuropathology 9th edn (CRC Press, 2015)."},{"key":"1081_CR4","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier, R. et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 20, 762\u2013772 (2021).","journal-title":"Lancet Neurol."},{"key":"1081_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley, M. P., Goldschmidt, C. H. & Rae-Grant, A. D. Diagnosis and treatment of multiple sclerosis: a review. JAMA 325, 765\u2013779 (2021).","journal-title":"JAMA"},{"key":"1081_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","volume":"19","author":"C Lubetzki","year":"2020","unstructured":"Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C. & Stankoff, B. Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol. 19, 678\u2013688 (2020).","journal-title":"Lancet Neurol."},{"key":"1081_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00401-015-1500-6","volume":"130","author":"K Blauth","year":"2015","unstructured":"Blauth, K. et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants. Acta Neuropathol. 130, 765\u2013781 (2015).","journal-title":"Acta Neuropathol."},{"key":"1081_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ana.21641","volume":"65","author":"GP Owens","year":"2009","unstructured":"Owens, G. P. et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann. Neurol. 65, 639\u2013649 (2009).","journal-title":"Ann. Neurol."},{"key":"1081_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473\u2013477 (2005).","journal-title":"J. Exp. Med."},{"key":"1081_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","volume":"17","author":"S Nielsen","year":"1997","unstructured":"Nielsen, S. et al. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 17, 171\u2013180 (1997).","journal-title":"J. Neurosci."},{"key":"1081_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bpa.12602","volume":"28","author":"R Min","year":"2018","unstructured":"Min, R. & van der Knaap, M. S. Genetic defects disrupting glial ion and water homeostasis in the brain. Brain Pathol. 28, 372\u2013387 (2018).","journal-title":"Brain Pathol."},{"key":"1081_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa1110740","volume":"367","author":"R Srivastava","year":"2012","unstructured":"Srivastava, R. et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N. Engl. J. Med. 367, 115\u2013123 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1081_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/cen3.12029","volume":"4","author":"M Watanabe","year":"2013","unstructured":"Watanabe, M., Yamasaki, R., Kawano, Y., Imamura, S. & Kira, J. Anti-KIR4.1 antibodies in Japanese patients with idiopathic central nervous system demyelinating diseases. Clin. Exp. Neuroimmunol. 4, 241\u2013242 (2013).","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"1081_CR14","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1177\/1352458514531086","volume":"20","author":"E Nerrant","year":"2014","unstructured":"Nerrant, E. et al. Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis. Mult. Scler. J. 20, 1699\u20131703 (2014).","journal-title":"Mult. Scler. J."},{"key":"1081_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(14)70141-3","volume":"13","author":"A Brickshawana","year":"2014","unstructured":"Brickshawana, A. et al. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study. Lancet Neurol. 13, 795\u2013806 (2014).","journal-title":"Lancet Neurol."},{"key":"1081_CR16","doi-asserted-by":"publisher","first-page":"e0129503","DOI":"10.1371\/journal.pone.0129503","volume":"10","author":"K Malyavantham","year":"2015","unstructured":"Malyavantham, K. et al. Humoral responses to diverse autoimmune disease-associated antigens in multiple sclerosis. PLoS One 10, e0129503 (2015).","journal-title":"PLoS One"},{"key":"1081_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMc1513302","volume":"374","author":"A Chastre","year":"2016","unstructured":"Chastre, A., Hafler, D. A. & O\u2019Connor, K. C. Evaluation of KIR4.1 as an immune target in multiple sclerosis. N. Engl. J. Med. 374, 1495\u20131496 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1081_CR18","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1212\/NXI.0000000000000263","volume":"3","author":"O Higuchi","year":"2016","unstructured":"Higuchi, O. et al. Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO. Neurol. Neuroimmunol. Neuroinflamm. 3, e263 (2016).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1081_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000452764","volume":"23","author":"R Zhong","year":"2017","unstructured":"Zhong, R. et al. Anti-KIR4.1 antibodies in Chinese patients with central nervous system inflammatory demyelinating disorders. Neuroimmunomodulation 23, 295\u2013300 (2017).","journal-title":"Neuroimmunomodulation"},{"key":"1081_CR20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1177\/1352458517711275","volume":"24","author":"M Marino","year":"2018","unstructured":"Marino, M. et al. Low reliability of anti-KIR4.183\u2013120 peptide auto-antibodies in multiple sclerosis patients. Mult. Scler. J. 24, 910\u2013918 (2018).","journal-title":"Mult. Scler. J."},{"key":"1081_CR21","doi-asserted-by":"publisher","first-page":"e0175538","DOI":"10.1371\/journal.pone.0175538","volume":"12","author":"M Navas-Madro\u00f1al","year":"2017","unstructured":"Navas-Madro\u00f1al, M. et al. Absence of antibodies against KIR4.1 in multiple sclerosis: a three-technique approach and systematic review. PLoS One 12, e0175538 (2017).","journal-title":"PLoS One"},{"key":"1081_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/1352458514551779","volume":"21","author":"L Brill","year":"2015","unstructured":"Brill, L. et al. Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse? Mult. Scler. 21, 572\u2013579 (2015).","journal-title":"Mult. Scler."},{"key":"1081_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jim.2017.03.008","volume":"445","author":"F Marnetto","year":"2017","unstructured":"Marnetto, F., Valentino, P., Caldano, M. & Bertolotto, A. Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients. J. Immunol. Methods 445, 53\u201358 (2017).","journal-title":"J. Immunol. Methods"},{"key":"1081_CR24","doi-asserted-by":"publisher","first-page":"fcad044","DOI":"10.1093\/braincomms\/fcad044","volume":"5","author":"AB Nicot","year":"2023","unstructured":"Nicot, A. B. et al. Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation. Brain Commun. 5, fcad044 (2023).","journal-title":"Brain Commun."},{"key":"1081_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1212\/WNL.0000000000000097","volume":"82","author":"V Kraus","year":"2014","unstructured":"Kraus, V. et al. Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease. Neurology 82, 470\u2013473 (2014).","journal-title":"Neurology"},{"key":"1081_CR26","doi-asserted-by":"publisher","first-page":"9632","DOI":"10.3390\/ijms21249632","volume":"21","author":"M Imamura","year":"2020","unstructured":"Imamura, M. et al. Anti-Kir4.1 antibodies in multiple sclerosis: specificity and pathogenicity. Int. J. Mol. Sci. 21, 9632 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1081_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5","volume":"26","author":"EA Nagelhus","year":"1999","unstructured":"Nagelhus, E. A. et al. Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Muller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains. Glia 26, 47\u201354 (1999).","journal-title":"Glia"},{"key":"1081_CR28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.neuroscience.2004.08.053","volume":"129","author":"EA Nagelhus","year":"2004","unstructured":"Nagelhus, E. A., Mathiisen, T. M. & Ottersen, O. P. Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 129, 905\u2013913 (2004).","journal-title":"Neuroscience"},{"key":"1081_CR29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.neuroscience.2009.10.028","volume":"168","author":"JE Rash","year":"2010","unstructured":"Rash, J. E. Molecular disruptions of the panglial syncytium block potassium siphoning and axonal saltatory conduction: pertinence to neuromyelitis optica and other demyelinating diseases of the central nervous system. Neuroscience 168, 982\u20131008 (2010).","journal-title":"Neuroscience"},{"key":"1081_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"1081_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","journal-title":"Science"},{"key":"1081_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.abm7930","volume":"375","author":"WH Robinson","year":"2022","unstructured":"Robinson, W. H. & Steinman, L. Epstein-Barr virus and multiple sclerosis. Science 375, 264\u2013265 (2022).","journal-title":"Science"},{"key":"1081_CR33","first-page":"160","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik, K., M\u00fcnz, C., Cohen, J. I. & Ascherio, A. Epstein\u2013Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat. Rev. Neurol. 19, 160\u2013171 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"1081_CR34","doi-asserted-by":"publisher","first-page":"578343","DOI":"10.1016\/j.jneuroim.2024.578343","volume":"390","author":"C M\u00fcnz","year":"2024","unstructured":"M\u00fcnz, C. Altered EBV specific immune control in multiple sclerosis. J. Neuroimmunol. 390, 578343 (2024).","journal-title":"J. Neuroimmunol."},{"key":"1081_CR35","doi-asserted-by":"publisher","first-page":"e1438","DOI":"10.1002\/cti2.1438","volume":"12","author":"TV Lanz","year":"2023","unstructured":"Lanz, T. V., Robinson, W. H., Ho, P. P. & Steinman, L. Roadmap for understanding mechanisms on how Epstein-Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trials. Clin. Transl. Immunol. 12, e1438 (2023).","journal-title":"Clin. Transl. Immunol."},{"key":"1081_CR36","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","volume":"186","author":"H Vietzen","year":"2023","unstructured":"Vietzen, H. et al. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis. Cell 186, 5705\u20135718.e13 (2023).","journal-title":"Cell"},{"key":"1081_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00415-024-12763-w","volume":"272","author":"M Comabella","year":"2024","unstructured":"Comabella, M. et al. Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis. J. Neurol. 272, 26 (2024).","journal-title":"J. Neurol."},{"key":"1081_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/glia.20640","volume":"56","author":"L Favre-Kontula","year":"2008","unstructured":"Favre-Kontula, L. et al. GlialCAM, an immunoglobulin-like cell adhesion molecule is 419 expressed in glial cells of the central nervous system. Glia 56, 633\u2013645 (2008).","journal-title":"Glia"},{"key":"1081_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ajhg.2011.02.009","volume":"88","author":"T Lopez-Hernandez","year":"2011","unstructured":"Lopez-Hernandez, T. et al. Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. Am. J. Hum. Genet. 88, 422\u2013432 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"1081_CR40","doi-asserted-by":"publisher","first-page":"548469","DOI":"10.3389\/fimmu.2021.548469","volume":"12","author":"PD Burbelo","year":"2021","unstructured":"Burbelo, P. D., Iadarola, M. J., Keller, J. M. & Warner, B. M. Autoantibodies targeting intracellular and extracellular proteins in autoimmunity. Front. Immunol. 12, 548469 (2021).","journal-title":"Front. Immunol."},{"key":"1081_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/B978-0-12-823912-4.00021-9","volume":"200","author":"JJ Linnoila","year":"2024","unstructured":"Linnoila, J. J. Paraneoplastic antibodies targeting intracellular antigens. Handb. Clin. Neurol. 200, 335\u2013346 (2024).","journal-title":"Handb. Clin. Neurol."},{"key":"1081_CR42","doi-asserted-by":"publisher","first-page":"744653","DOI":"10.3389\/fneur.2021.744653","volume":"12","author":"JE Greenlee","year":"2022","unstructured":"Greenlee, J. E. et al. Paraneoplastic and other autoimmune encephalitides: antineuronal antibodies, T lymphocytes, and questions of pathogenesis. Front. Neurol. 12, 744653 (2022).","journal-title":"Front. Neurol."},{"key":"1081_CR43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/jnnp-2023-332643","volume":"95","author":"E Johansson","year":"2024","unstructured":"Johansson, E. et al. Head trauma results in manyfold increased risk of multiple sclerosis in genetically susceptible individuals. J. Neurol. Neurosurg. Psychiatry 95, 554\u2013560 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1081_CR44","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/ana.25036","volume":"82","author":"S Montgomery","year":"2017","unstructured":"Montgomery, S. et al. Concussion in adolescence and risk of multiple sclerosis. Ann. Neurol. 82, 554\u2013561 (2017).","journal-title":"Ann. Neurol."},{"key":"1081_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","volume":"2","author":"CL Vanderlugt","year":"2002","unstructured":"Vanderlugt, C. L. & Miller, S. D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2, 85\u201395 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"1081_CR46","doi-asserted-by":"publisher","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann, H. Multiple sclerosis pathology. Cold Spring Harb. Perspect. Med. 8, a028936 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1081_CR47","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/jnnp-2014-307712","volume":"85","author":"L Haider","year":"2014","unstructured":"Haider, L. et al. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J. Neurol. Neurosurg. Psychiatry 85, 1386\u20131395 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1081_CR48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.21800","volume":"66","author":"AP Henderson","year":"2009","unstructured":"Henderson, A. P., Barnett, M. H., Parratt, J. D. & Prineas, J. W. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann. Neurol. 66, 739\u2013753 (2009).","journal-title":"Ann. Neurol."},{"key":"1081_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/jnen\/nly121","volume":"78","author":"JW Prineas","year":"2019","unstructured":"Prineas, J. W. & Lee, S. Multiple sclerosis: destruction and regeneration of astrocytes in acute lesions. J. Neuropathol. Exp. Neurol. 78, 140\u2013156 (2019).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1081_CR50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ana.26585","volume":"93","author":"AMR van den Bosch","year":"2023","unstructured":"van den Bosch, A. M. R. et al. Ultrastructural axon-myelin unit alterations in multiple sclerosis correlate with inflammation. Ann. Neurol. 93, 856\u2013870 (2023).","journal-title":"Ann. Neurol."},{"key":"1081_CR51","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/ana.26014","volume":"89","author":"A Luchicchi","year":"2021","unstructured":"Luchicchi, A. et al. Axon-myelin unit blistering as early event in MS normal appearing white matter. Ann. Neurol. 89, 711\u2013725 (2021).","journal-title":"Ann. Neurol."},{"key":"1081_CR52","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/acn3.52015","volume":"11","author":"A Luchicchi","year":"2024","unstructured":"Luchicchi, A. et al. Micro-diffusely abnormal white matter: an early multiple sclerosis lesion phase with intensified myelin blistering. Ann. Clin. Transl. Neurol. 11, 973\u2013988 (2024).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1081_CR53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.22443","volume":"61","author":"CF Brosnan","year":"2013","unstructured":"Brosnan, C. F. & Raine, C. S. The astrocyte in multiple sclerosis revisited. Glia 61, 453\u2013465 (2013).","journal-title":"Glia"},{"key":"1081_CR54","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/1352458510382324","volume":"16","author":"JD Parratt","year":"2010","unstructured":"Parratt, J. D. & Prineas, J. W. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult. Scler. 16, 1156\u20131172 (2010).","journal-title":"Mult. Scler."},{"key":"1081_CR55","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/brain\/awab394","volume":"145","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. Spectrum of sublytic astrocytopathy in neuromyelitis optica. Brain 145, 1379\u20131390 (2022).","journal-title":"Brain"},{"key":"1081_CR56","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/brain\/awaa102","volume":"143","author":"Y Takai","year":"2020","unstructured":"Takai, Y. et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain 143, 1431\u20131446 (2020).","journal-title":"Brain"},{"key":"1081_CR57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/WNL.0000000000002844","volume":"87","author":"JJ Wang","year":"2016","unstructured":"Wang, J. J. et al. Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD. Neurology 87, 229\u2013231 (2016).","journal-title":"Neurology"},{"key":"1081_CR58","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","volume":"139","author":"R Hoftberger","year":"2020","unstructured":"Hoftberger, R. et al. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 139, 875\u2013892 (2020).","journal-title":"Acta Neuropathol."},{"key":"1081_CR59","doi-asserted-by":"publisher","first-page":"1209749","DOI":"10.3389\/fneur.2023.1209749","volume":"14","author":"Y Takai","year":"2023","unstructured":"Takai, Y., Misu, T., Fujihara, K. & Aoki, M. Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. Front. Neurol. 14, 1209749 (2023).","journal-title":"Front. Neurol."},{"key":"1081_CR60","doi-asserted-by":"publisher","first-page":"1137998","DOI":"10.3389\/fneur.2023.1137998","volume":"14","author":"O Corbali","year":"2023","unstructured":"Corbali, O. & Chitnis, T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front. Neurol. 14, 1137998 (2023).","journal-title":"Front. Neurol."},{"key":"1081_CR61","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(12)70192-8","volume":"11","author":"MS van der Knaap","year":"2012","unstructured":"van der Knaap, M. S., Boor, I. & Estevez, R. Megalencephalic leukoencephalopathy with subcortical cysts: chronic white matter oedema due to a defect in brain ion and water homoeostasis. Lancet Neurol. 11, 973\u2013985 (2012).","journal-title":"Lancet Neurol."},{"key":"1081_CR62","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1086\/319519","volume":"68","author":"Leegwater","year":"2001","unstructured":"Leegwater et al. Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am. J. Hum. Genet. 68, 831\u2013838 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"1081_CR63","doi-asserted-by":"publisher","first-page":"1352947","DOI":"10.3389\/fgene.2024.1352947","volume":"15","author":"EMJ Passchier","year":"2024","unstructured":"Passchier, E. M. J. et al. Megalencephalic leukoencephalopathy with subcortical cysts: a variant update and review of the literature. Front. Genet. 15, 1352947 (2024).","journal-title":"Front. Genet."},{"key":"1081_CR64","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1093\/brain\/awad146","volume":"146","author":"EMJ Passchier","year":"2023","unstructured":"Passchier, E. M. J. et al. Aquaporin-4 and GPRC5B: old and new players in controlling brain oedema. Brain 146, 3444\u20133454 (2023).","journal-title":"Brain"},{"key":"1081_CR65","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1474-4422(13)70053-X","volume":"12","author":"C Depienne","year":"2013","unstructured":"Depienne, C. et al. Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study. Lancet Neurol. 12, 659\u2013668 (2013).","journal-title":"Lancet Neurol."},{"key":"1081_CR66","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1126\/science.8266101","volume":"262","author":"J Bergoffen","year":"1993","unstructured":"Bergoffen, J. et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262, 2039\u20132042 (1993).","journal-title":"Science"},{"key":"1081_CR67","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJMoa0810276","volume":"360","author":"D Bockenhauer","year":"2009","unstructured":"Bockenhauer, D. et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N. Engl. J. Med. 360, 1960\u20131970 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1081_CR68","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.1073\/pnas.0901749106","volume":"106","author":"UI Scholl","year":"2009","unstructured":"Scholl, U. I. et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc. Natl Acad. Sci. USA 106, 5842\u20135847 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1081_CR69","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00415-018-8826-7","volume":"265","author":"M Severino","year":"2018","unstructured":"Severino, M. et al. Unusual white matter involvement in EAST syndrome associated with novel KCNJ10 mutations. J. Neurol. 265, 1419\u20131425 (2018).","journal-title":"J. Neurol."},{"key":"1081_CR70","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/(SICI)1096-9861(19971117)388:2<265::AID-CNE6>3.0.CO;2-#","volume":"388","author":"JE Rash","year":"1997","unstructured":"Rash, J. E. et al. Grid-mapped freeze-fracture analysis of gap junctions in gray and white matter of adult rat central nervous system, with evidence for a \u201cpanglial syncytium\u201d that is not coupled to neurons. J. Comp. Neurol. 388, 265\u2013292 (1997).","journal-title":"J. Comp. Neurol."},{"key":"1081_CR71","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/brain\/awr255","volume":"134","author":"MC Ridder","year":"2011","unstructured":"Ridder, M. C. et al. Megalencephalic leucoencephalopathy with cysts: defect in chloride currents and cell volume regulation. Brain 134, 3342\u20133354 (2011).","journal-title":"Brain"},{"key":"1081_CR72","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/ana.25190","volume":"83","author":"M Dubey","year":"2018","unstructured":"Dubey, M. et al. Seizures and disturbed brain potassium dynamics in the leukodystrophy megalencephalic leukoencephalopathy with subcortical cysts. Ann. Neurol. 83, 636\u2013649 (2018).","journal-title":"Ann. Neurol."},{"key":"1081_CR73","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.nbd.2011.03.015","volume":"43","author":"A Duarri","year":"2011","unstructured":"Duarri, A. et al. Knockdown of MLC1 in primary astrocytes causes cell vacuolation: a MLC disease cell model. Neurobiol. Dis. 43, 228\u2013238 (2011).","journal-title":"Neurobiol. Dis."},{"key":"1081_CR74","doi-asserted-by":"publisher","first-page":"e71379","DOI":"10.7554\/eLife.71379","volume":"10","author":"A Gilbert","year":"2021","unstructured":"Gilbert, A. et al. Megalencephalic leukoencephalopathy with subcortical cysts is a developmental disorder of the gliovascular unit. eLife 10, e71379 (2021).","journal-title":"eLife"},{"key":"1081_CR75","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1152\/physrev.00011.2013","volume":"93","author":"EA Nagelhus","year":"2013","unstructured":"Nagelhus, E. A. & Ottersen, O. P. Physiological roles of aquaporin-4 in brain. Physiol. Rev. 93, 1543\u20131562 (2013).","journal-title":"Physiol. Rev."},{"key":"1081_CR76","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1073\/pnas.1012867108","volume":"108","author":"V Benfenati","year":"2011","unstructured":"Benfenati, V. et al. An aquaporin-4\/transient receptor potential vanilloid 4 (AQP4\/TRPV4) complex is essential for cell-volume control in astrocytes. Proc. Natl Acad. Sci. USA 108, 2563\u20132568 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1081_CR77","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1471-4159.2006.04164.x","volume":"100","author":"V Benfenati","year":"2007","unstructured":"Benfenati, V. et al. Functional down-regulation of volume-regulated anion channels in AQP4 knockdown cultured rat cortical astrocytes. J. Neurochem. 100, 87\u2013104 (2007).","journal-title":"J. Neurochem."},{"key":"1081_CR78","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s00429-014-0767-z","volume":"220","author":"NN Haj-Yasein","year":"2015","unstructured":"Haj-Yasein, N. N. et al. Deletion of aquaporin-4 increases extracellular K+ concentration during synaptic stimulation in mouse hippocampus. Brain Struct. Funct. 220, 2469\u20132474 (2015).","journal-title":"Brain Struct. Funct."},{"key":"1081_CR79","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/hmg\/ddab155","volume":"30","author":"M Alonso-Gardon","year":"2021","unstructured":"Alonso-Gardon, M. et al. Identification of the GlialCAM interactome: the G protein-coupled receptors GPRC5B and GPR37L1 modulate megalencephalic leukoencephalopathy proteins. Hum. Mol. Genet. 30, 1649\u20131665 (2021).","journal-title":"Hum. Mol. Genet."},{"key":"1081_CR80","doi-asserted-by":"publisher","first-page":"11354","DOI":"10.1523\/JNEUROSCI.0723-07.2007","volume":"27","author":"B Djukic","year":"2007","unstructured":"Djukic, B., Casper, K. B., Philpot, B. D., Chin, L. S. & McCarthy, K. D. Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J. Neurosci. 27, 11354\u201311365 (2007).","journal-title":"J. Neurosci."},{"key":"1081_CR81","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrn3275","volume":"13","author":"PK Stys","year":"2012","unstructured":"Stys, P. K., Zamponi, G. W., van Minnen, J. & Geurts, J. J. Will the real multiple sclerosis please stand up? Nat. Rev. Neurosci. 13, 507\u2013514 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"1081_CR82","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/acn3.51401","volume":"8","author":"BA 't Hart","year":"2021","unstructured":"'t Hart, B. A., Luchicchi, A., Schenk, G. J., Stys, P. K. & Geurts, J. J. G. Mechanistic underpinning of an inside-out concept for autoimmunity in multiple sclerosis. Ann. Clin. Transl. Neurol. 8, 1709\u20131719 (2021).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1081_CR83","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.expneurol.2016.04.002","volume":"283","author":"ID Duncan","year":"2016","unstructured":"Duncan, I. D. & Radcliff, A. B. Inherited and acquired disorders of myelin: the underlying myelin pathology. Exp. Neurol. 283, 452\u2013475 (2016).","journal-title":"Exp. Neurol."},{"key":"1081_CR84","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/BF00593394","volume":"37","author":"MS van der Knaap","year":"1995","unstructured":"van der Knaap, M. S. et al. Leukoencephalopathy with swelling in children and adolescents: MRI patterns and differential diagnosis. Neuroradiology 37, 679\u2013686 (1995).","journal-title":"Neuroradiology"},{"key":"1081_CR85","doi-asserted-by":"publisher","first-page":"e1395","DOI":"10.1212\/WNL.0000000000005334","volume":"90","author":"EMC Hamilton","year":"2018","unstructured":"Hamilton, E. M. C. et al. Megalencephalic leukoencephalopathy with subcortical cysts: characterization of disease variants. Neurology 90, e1395\u2013e1403 (2018).","journal-title":"Neurology"},{"key":"1081_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson, T., Barcellos, L. F. & Alfredsson, L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat. Rev. Neurol. 13, 25\u201336 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"1081_CR87","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm.3897","volume":"21","author":"JH Cho","year":"2015","unstructured":"Cho, J. H. & Feldman, M. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat. Med. 21, 730\u2013738 (2015).","journal-title":"Nat. Med."},{"key":"1081_CR88","doi-asserted-by":"publisher","first-page":"e200374","DOI":"10.1212\/NXI.0000000000200374","volume":"12","author":"JR Dahl","year":"2025","unstructured":"Dahl, J. R. et al. Modulator of VRAC current 1 is a potential target antigen in multiple sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 12, e200374 (2025).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1081_CR89","doi-asserted-by":"publisher","first-page":"e200383","DOI":"10.1212\/NXI.0000000000200383","volume":"12","author":"JJ Sabatino Jr","year":"2025","unstructured":"Sabatino, J. J. Jr & Steinman, L. Multiple sclerosis: a virus-induced gliopathy? Neurol. Neuroimmunol. Neuroinflamm. 12, e200383 (2025).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"1081_CR90","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1073\/pnas.1518553113","volume":"113","author":"B Ayoglu","year":"2016","unstructured":"Ayoglu, B. et al. Anoctamin 2 identified as an autoimmune target in multiple sclerosis. Proc. Natl Acad. Sci. USA 113, 2188\u20132193 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1081_CR91","doi-asserted-by":"publisher","first-page":"16955","DOI":"10.1073\/pnas.1902623116","volume":"116","author":"K Tengvall","year":"2019","unstructured":"Tengvall, K. et al. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk. Proc. Natl Acad. Sci. USA 116, 16955\u201316960 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1081_CR92","doi-asserted-by":"publisher","first-page":"eadg3032","DOI":"10.1126\/sciadv.adg3032","volume":"9","author":"OG Thomas","year":"2023","unstructured":"Thomas, O. G. et al. Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis. Sci. Adv. 9, eadg3032 (2023).","journal-title":"Sci. Adv."},{"key":"1081_CR93","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","volume":"15","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff, R. M. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat. Neurosci. 15, 1074\u20131077 (2012).","journal-title":"Nat. Neurosci."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01081-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01081-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01081-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:02:17Z","timestamp":1746518537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01081-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1038\/s41582-025-01081-y","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"18 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}